ADA in Biological Technology

Data on VIVUS' Qnexa To Be Presented During Two Podium Presentations at ADA Annual Meeting

MOUNTAIN VIEW, Calif., June 2 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS ), a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes and sexual health, today announced that Qnexa data will be featured in two podium presenta...

Oramed Pharmaceuticals to Present Oral Insulin Trial Results at ADA Conference (June 6-10, San Francisco)

JERUSALEM, June 4 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com ), a developer of oral delivery systems, announced today that it has been selected to display its abstract, entitled Pharmacokinetics (PK) and Pharmacodynamics (PD) of Oral Insulin...

Corgenix to Exhibit AspirinWorks(R) Test at ADA 2008 Meeting in San Francisco

DENVER, June 4 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, is exhibiting its AspirinWorks(R) Test at the American Diabetes Association's 68th Scientific Sessions. The exhibits are open Saturday t...

Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008

SAN DIEGO, June 2 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) today announced that the company will present new data for its FDA-approved diabetes drugs, BYETTA(R) (exenatide) injection and SYMLIN(R) (pramlintide acetate) injection, and its pipeline diabetes and obe...

Sangamo BioSciences Reports Second Quarter 2009 Financial Results

... partially offset by increased clinical trial expenses. Recent Highlights Presentation of positive Phase 2 ZFP Therapeutic data at ada 2009. Sangamo announced the presentation of previously unreleased positive Phase 2 clinical data from its ZFP Therapeutic(TM) program to develop SB-5...

Data for SemBioSys' insulin to be presented at the American Diabetes Association's 69th Scientific Sessions

...ivalence of Recombinant Human Insulin from Transgenic Plants," by Joseph Boothe and colleagues. The abstract for the presentation is available via the ada website at http://ww2.aievolution.com/ada0901/index.cfm?do=abs.viewAbs&abs=7845 . The poster presentation details the clinical trial results of...

Orexigen(R) Therapeutics Announces Upcoming Data Presentations at American Diabetes Association and Endocrine Society Annual Scientific Meetings

...es Association (ADA) 69th Scientific Sessions, June 5-9, 2009, and the 91st Annual Meeting of the Endocrine Society (ENDO), June 10-13, 2009. ada : Ernest N. Morial Convention Center, New Orleans , LA. Saturday, June 6: Embargo Lifts June 6 at 9:00 a.m. CT Oral Presentatio...

Intarcia Therapeutics, Inc. Announces Acceptance of ITCA 650 Phase 1b Study for Late-Breaker Presentation at the American Diabetes Association 69th Scientific Sessions

..., D., Weiner, G., Denham, D. and Alessi, T. "We are very pleased the ada scientific reviewers selected our study for presentation as a late-breaker,...g a more complete analysis of 28-day results from all four dose arms at the ada Conference." ITCA 650 therapy in this phase 1 trial is administered fo...

Nearly 70 Percent of Health Professionals Support Biotechnology's Use in Food Products

... enhance the quality, safety and nutritional value of food. In its position statement published in the Journal of the American Dietetic Association , ada encourages the availability of these products in the marketplace. Consumers have long recognized soyfoods as healthy, as well. USB's Consumer ...

AFL To Return to Oklahoma Due to Overwhelming Demand for Signalife Heart Screening

...first series of tests, we identified a life threatening condition in a local 16 year old, which on its own justifies our program. I plan to be back in ada to help raise awareness about heart disease and visit with the young man and his family." The Foundation is performing heart screening at its traile...

CV Therapeutics Announces Presentations at the American Diabetes Association 68th Scientific Sessions

...k for Diabetes and Metabolic Syndrome; Poster; Sunday, June 8, 2008, 12:00 - 2:00 p.m. and 6:15 - 7:30 p.m. PDT Additional information regarding the ada 68th Scientific Sessions can be accessed at http://professional.diabetes.org/Congress_Display.aspx?TYP=9&CID=58000 . About CV Therapeutics CV The...

Good Neighbor Pharmacy(R) Ironman Competitor Inspires Individuals with Diabetes to Live Without Limits

...ile a number of people who have been inspired by Andy's story. The website also posts Andy's schedule for the upcoming year. Feb. 2: Sandy, Utah; ada Expo Salt Lake City Mar. 29: Oceanside, Calif.; Ford Ironman 70.3 Apr. 13: Tempe, Ariz.; Ford Ironman Arizona May 4: Cincinnati, Ohio; Flying Pig ...

Management Perspectives: Outsource HR

...pliance issues continues to climb. Since 1980, the number of laws that apply to employers has doubled. The alphabet soup of federal laws FMLA, COBRA, ada threatens to drown even the most vigilant business owner. Just as important, Oltman says, is the savings his company realizes by not having to su...